Catherine Novack | BiotechTV

top of page

Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

She gives a scenario analysis in the event that FDA asked Capricor for more data rather than approving the therapy by its August 31st...

Bright Minds

Jun 27

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Catherine Novack and Debanjana Chatterjee share their take on biotech and comment on companies they cover

They discusses the macro and regulatory factors that have affected the sector so strongly, and comment on Wave, Korro, ProQr, Capricor,...

Bright Minds

Apr 9

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page

Jones Research analyst Catherine Novack discusses Capricor's regulatory roller coaster, RNA editing, and more

Jones Healthcare & Technology Innovation Conference: Jones Research analysts Catherine Novack and Debanjana Chatterjee share their take on biotech and comment on companies they cover

Follow BiotechTV

Sponsors

Sponsor Spotlight